TerraBioGen Technologies Inc.
TSX VENTURE : TBG

TerraBioGen Technologies Inc.

January 24, 2011 09:30 ET

IBR Changes Name to Terrabiogen

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Jan. 24, 2011) - Terrabiogen Technologies Inc., formerly International Bio Recovery Corporation (TSX VENTURE:TBG) -

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES

International Bio Recovery Corporation, a developer and marketer of proprietary technologies for the production of organic-based, high-value agricultural products from organic wastes, is pleased to announce that it has changed its name to Terrabiogen Technologies Inc. effective January 21, 2011. All regulatory approvals have been received for the name change and the Company's new trading symbol on the TSX Venture Exchange is TBG.

The Company is in the process of developing a new website and will be transitioning all IBR documents to that site by February 1, 2011.

Blair Heffelfinger, President and CEO of the Company stated, "the name change to Terrabiogen Technologies Inc. signifies a new beginning for the company. Over the past 15 months, 6 of the 8 directors are new to the company. I joined the company in May last year and was appointed President and CEO on September 1, 2010. During this period, we have expanded our research team and are building on our technical expertise. We will also be working with strategic partners in our growing trials and are nearing the completion of a process review to reduce the capital cost and operating costs of future plants."

About Terrabiogen

Located in North Vancouver, BC, Terrabiogen Technologies Inc. is committed to research and development to continue to improve the efficiency of its technology and the quality of its agricultural products. It is further committed to developing a world wide marketing capability to ensure market acceptance of its products.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although IBR believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of IBR's management on the date the statements are made. Except as required by law, IBR undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • Terrabiogen
    Blair Heffelfinger
    President & CEO
    (604) 924-1023 ext 316
    (604) 924-1043 (FAX)
    or
    Terrabiogen
    Bob Nowell
    CFO & Corporate Secretary
    (604) 924-1023 ext 306
    (604) 924-1043 (FAX)